RDIF, Adienne Pharma & Biotech collaborate for the production of Sputnik V in Italy – Business & Economy | Instant News


TASS, March 8. The Russian Direct Investment Fund (RDIF) will work with Switzerland-based Adienne Pharma & Biotech for the production of the Sputnik V coronavirus vaccine in Italy, said RDIF chief executive Kirill Dmitriev in an interview with Italian TV Channel Rai 3.

“We are in talks with the Italian government. There are many regions that are enthusiastic about Sputnik V, which wants to produce it domestically. We are now working with the Swiss company Adienne Pharma & Biotech on the production of Sputnik V in Italy for the first time,” said Dmitriev. .

The manufacturing mechanism will help create new jobs and give Italy the opportunity to control products.

Production of Sputnik V in Italy can start as early as June. RDIF will announce 20 cooperative projects in ten countries, including Italy, at the end of this parade, said the chief executive. In particular, the IMF is discussing cooperation with Germany and France right now.

Sputnik V ranks second among vaccines in terms of approvals received from government regulators.



image source

to request modification Contact us at Here or [email protected]